Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-19

Clinical Trial Update: Effect of Debridement-scaling on the Relief of Dry Eye Signs and Symptoms in Sjogren's Syndrome [NA]

View source ↗

Summary

This completed clinical trial evaluates whether debridement-scaling reduces dry eye signs and symptoms in people with Sjögren's syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Waterloo | Conditions: Sjogren's Syndrome | NA | Status: COMPLETED